Protective effect of Ginkgo biloba extract on testicular tissue of diabetic rats

AIM: To investigate the protective effect of Ginkgo biloba extract (GBE) on diabetic testis and explore its possible mechanism. METHODS: Testicular structure of streptozotocin-induced diabetic rats was observed under light microscopy (LM) and transmission electron microscopy (TEM). Content of malondialdehyde (MDA), NO₂^-/NO₃^- and activity of superoxide dismutase (SOD), nitric oxide synthase (NOS) were determined in testicular homogenate. RESULTS: In diabetic rats, it was manifestated as deformation of seminiferous tubule, atrophy and shedding of germinal epithelium under LM, while expansion of smooth endoplasmic reticulum, formation of fatty vacuoles and decrease of lysosome obviously in the cytoplasm of sertoli cell under TEM, the injury of testicular tissue was improved by GBE. Compared with diabetic rats, activity of SOD increased while activity of tNOS and iNOS, content of MDA and NO₂^-/NO₃^- decreased in GBE-treated rats. CONCLUSION: GBE could effectively prevent the development of diabetic testis and the effect may be partly achieved by resisting lipid peroxidation,restraining the activity of testicular tissue iNOS and reducing the pathological alterations of NO.     

Protective effects of extract of Ginkgo biloba on diaphragm of diabetic rats

AIM: To investigate the effects of extract of Ginkgo biloba (EGb) on diaphragm from diabetic rats. METHODS: Sprague-Dauley rats were divided into three groups: normal control, diabetic group and EGb treatment group. The morphologic changes of diaphragm tissues were studied by light and electron microscopy, the activities of succinate dehydrogenase (SDH), superoxide dismutase (SOD), nitric oxide synthase (NOS) and contents of malondialdehyde (MDA), nitric oxide (NO₂^-/NO₃-) in the diaphragm mitochondria were assayed by spectophotometer, respectively. RESULTS: The activities of SOD, SDH decreased in diabetic diaphragm mitochondria, but the activitiy of NOS, the contents of NO₂^-/NO₃^-, MDA increased compared with control group. The activities of SOD, SDH were increased as well as NOS were decreased and the contents of NO₂^-/NO₃^-, MDA decreased in EGb treatment group compared with the diabetic group. CONCLUSION: EGb may protects the diaphragm mitochondria of diabetic rats by enhancing the function of respiratory chain, anti-oxidation and decreasing NO level.     

Effect of lentinan on myocardial impairment in diabetic rats

AIM:To study the protective effect of lentinan against myocardial impairment in diabetic rats.METHODS:Morphology of myocardium from streptozocin induced diabetic rats treated with lentinan was observed under light microscopy(LM) and transmission electron microscopy(TEM). Activity of superoxide dismutase(SOD), nitric oxide synthase (NOS) and contents of malondialdehyde (MDA) and nitric oxide (NO) were detected biochemically in myocardial homogenate.RESULTS:Vacuolar degeneration, local lysis of myocardium and interstitial proliferation under LM and expansion of mitochondria, shortening of mitochondrial crest, lysis of myofibril and proliferation of interstitial collogenous fiber under TEM were observed. The activity of SOD decreased and the activity of NOS, the contents of NO, MDA increased, but the morphological change became slight in LNT-treatment group. Activity of SOD increased while activity of NOS and contents of MDA, NO decreased in LNT-treated rats compared with diabetic rats.CONCLUSION:LNT protectes diabetic myocardium, and the anti-lipid peroxidation and decreasing of NO level may be involved in it.     

Effect of Ginkgo biloba extract on retinopathy in diabetic rats

AIM: To investigate the effect of Ginkgo biloba extract(GBE) on diabetic retinopathy(DR) and its possible mechanism in rats. METHODS: Goto-Kakizaki(GK) rats were used as a DR model, and were treated with different doses of GBE. Normal Wistar rats were used as the control. Blood glucose and retina barrier injury were analyzed, respectively. Ganglion cell apoptosis was detected by TUNEL staining. Moreover, the protein expression of nuclear factor E2-related factor 2(Nrf2), ERK, Bcl-2 and P53, and ERK phosphorylation were examined by Western blot.RESULTS: GBE reduced blood glucose in the DR rats, attenuated retina barrier injury, and decreased the apoptosis of ganglion cells. Furthermore, the expression of Nrf2 and Bcl-2, and phosphorylation of ERK were increased after GBE treatment, whereas P53 expression was decreased. CONCLUSION: GBE protects ganglion cells against apoptosis in DR rats, which may be through activation of Nrf2/ERK pathway and regulating Bcl-2 and P53 expression.     

Effect of curcumin derivative B06 on liver from type 2 diabetic rats

AIM:To observe the protective effect of curcumin derivative B06 on the liver from the rats with hyperlipidemia and type 2 diabetes mellitus. METHODS:Male Sprague-Dawley rats (n=35) were divided randomly into 5 groups: normal control group, high-fat group, high-fat+B06-treated group, diabetic group and diabetic +B06-treated group. After fed with a high-fat diet for 4 weeks, the rats in the later 2 groups were injected with streptozotocin intraperitoneally to induce type 2 diabetes mellitus. The rats in B06-treated groups were given B06 by gavage at a dose of 0.2 mg· kg-1·d-1 for 8 weeks. After the treatment, the morphology of the liver was observed under light and transmission electron microscopes. The protein expression of AMP-activated protein kinase α (AMPKα) and phosphorylated AMPK α (p-AMPKα) was detected by Western blotting. RESULTS:Fatty degeneration, hepatocellular necrosis, inflammatory cell infiltration and hyperplasia of fibrous tissue were observed in the liver from the rats in high-fat group and diabetic group,and were relieved after B06 treatment. The protein expression of p-AMPKα was decreased in the liver of the rats in diabetic group and high-fat group, and it was increased in the liver of the high-fat and diabetic rats in B06-treated group. CONCLUSION:Curcumin derivative B06 exerts a protective effect on the liver in type 2 diabetic rats, and the increased expression of p-AMPKα may be involved in the mechanism of protection.     

Effect of EGB on pituitary-testicular axis and expressions of LHR and StAR in type II diabetic rats

AIM: To observe the effect of the extract of Ginkgo biloba(EGB) on pituitary-testicular axis and the mRNA expressions of luteinizing hormone receptor (LHR) and steroidogenic acute regulatory protein (StAR). METHODS: Thirty male Sprague-Dauley rats were divided into three groups randomly: normal control group, type II diabetic group and EGB treatment group. After fed with high-fat diet for 4 weeks, the later two groups were injected with strepozotocin intraperitoneally to induce type II diabetes mellitus. The EGB treatment group was given EGB at the dose of 50 mg/kg once a day for 12 weeks by intragastric administration. The normal control and diabetic group were given normal saline of equal volume per day for 12 weeks. The indices of blood glucose, insulin and low-density lipoprotein-cholesterol (LDL-c) were measured. The morphologic change of testicular tissue was observed under light microscopy (LM) and transmission electron microscopy (TEM) respectively. The concentrations of blood luteinizing hormone (LH) and testosterone (T) were assayed by the technique of enzyme linked immunosorbent assay (ELISA). The mRNA expressions of LHR and StAR from Leydig cells were detected by RT-PCR. RESULTS: The concentrations of blood glucose, insulin and LDL-c increased obviously, and the testis weights lessened obviously in type II diabetic groups compared to those in normal control groups. Rare spermatogenic cells of seminiferous tubule and germinal arrest were observed in diabetic group under LM. Ultrastructural analysis of testicular tissue by TEM showed dilation of the endoplasmic reticulum and mitochondrial swelling in Leydig cell and sertoli cell in diabetic group. The level of blood LH and T decreased in type II diabetic groups in comparison with that in the normal control group. Compared to normal groups, the mRNA expression of StAR in type II diabetic groups decreased, while the mRNA expression of LHR increased. After the treatment of EGB, the pathological change of testis was relieved, the concentrations of blood glucose, insulin and LDL-c were decreased, the level of blood LH and T, and the mRNA expression of StAR were increased, and the mRNA expression of LHR descended compared to type II diabetic groups. CONCLUSION: EGB may increase the LH-induced testosterone production by correcting metabolic disorder of glucose and lipid, improving the function of pituitary-testicular axis and regulating the expression of LHR and StAR mRNA.     

Effects of Ginkgo biloba extract on myocardial TGF-β1 and collagen expression and interstitial fibrosis in type I diabetic cardiomyopathy rats

AIM:To study the effects of Ginkgo biloba extract (EGB) on myocardial TGF-β1 and collagen expression and interstitial fibrosis in type I diabetic cardiomyopathy rats. METHODS:Thirty male SD rats were randomly divided into normal control group (CON), diabetes mellitus group (DM) and EGB treatment group (EGB). Streptozocin was intraperitoneally injected into the animals in the latter 2 groups to induce type I diabetic rat model. The rats in EGB group were intraperitoneally injected with EGB. At the end of the 12th week, the body weight of each rat and its left ventri-cular weight, blood glucose, glycosylated hemoglobin and serum insulin concentration were measured. The left ventricular end-diastolic volume (LVEDV), the left ventricular end-systolic volume (LVESV), the left ventricular ejection fraction (LVEF) and the stroke volume (SV) were determined by echocardiography. The content of collagen in left ventricular myocardium, and the expression of transforming growth factor β1 (TGF-β1), procollagen type I and collagen type III were assayed by Sirius red staining, immunohistochemical staining and RT-PCR, respectively. Left ventricular myocardial cells of the neonatal SD rats were isolated and cultured in vitro with low-glucose culture medium (LG group), high-glucose culture medium (HG group) or high-glucose culture medium plus EGB (HG+EGB group). The mRNA levels of TGF-β1, procollagen type I and collagen type III were detected by RT-PCR. RESULTS:Compared with CON group, blood glucose, glycosylated hemoglobin, left ventricular weight index, the content of collagen, and the expression of TGF-β1, procollagen type I and collagen type III in left ventricular myocardial tissues of DM group were significantly increased, while the levels of blood insulin, LVEDV and SV were significantly decreased. However, compared with DM group, blood glucose, glycosylated hemoglobin, left ventricule weight index, the content of collagen, and the expression levels of TGF-β1, procollagen type I and collagen type III in the left ventricular myocardial tissues of EGB-treated rats were significantly decreased, while the levels of blood insulin, LVEDV and SV were significantly increased. Compared with LG group, the mRNA expression levels of TGF-β1, procollagen type I and collagen type III were significantly increased. However, compared with HG group, the mRNA expression levels of TGF-β1, procollagen type I and collagen type III were significantly decreased after treated with EGB. CONCLUSION: EGB retards the process of myocardial fibrosis and improves the cardiac functions in type I diabetic cardiomyopathy rats by down-regulating the expression of TGF-β1, reducing the synthesis and deposition of collagen type I and collagen type III.     

Effects of extract of gingko biloba on expression of glucocorticoid receptor in hepatic tissues from type 2 diabetic rats

AIM: To study the effect and mechanism of extract of ginkgo biloba (EGB) on liver glucocorticoid receptor (GR) expression in type 2 diabetic rats. METHODS: Thirty male Sprague-Dawley rats were divided randomly into three groups: normal control group (n=10), type 2 diabetic group (n=10) and ginkgo biloba treated group (n=10). After fed with high-fat feeding for 4 weeks, the later two groups were injected with streptozotocin at a dose of 30 mg/kg intraperitoneally to induce type 2 diabetic rat model. The EGB treated group was gavaged with EGB at the dose of 50 mg·kg-1·d-1 for 12 weeks. At the end of experiment, the rats were sacrificed, the blood glucose, serum lipid and blood insulin were measured. The morphology of liver tissue was observed under light microscopy with HE staining. GR mRNA expression in liver was measured by RT-PCR. The level of GR protein expression in liver tissue was detected by immunohistochemistry. RESULTS: EGB reduced the levels of blood glucose, blood lipids, blood insulin in diabetic rats. EGB also relieved fatty degeneration and necrosis of the hepatic cells, ameliorated infiltration of inflammatory cells in the liver; and decreased GR expression at both mRNA and protein levels in diabetic liver. CONCLUSION: EGB may inhibit GR expression in liver of type 2 diabetic rats, which results in decreasing the level of blood glucose, blood lipid, blood insulin and relieving the liver damage in type diabetic rats.     

Insulin and gliclazide therapies improve liver lipid deposition in type 2 diabetic rats

AIM：To investigate the effect of insulin and gliclazide therapies on the liver fat accumulation in type 2 diabetic rats. METHODS：A high-fat diet plus low-dose streptozotocin was implemented to establish a type 2 diabetic rat model, and the rats were randomly divided into diabetes mellitus (DM) group, diabetic rats treated with insulin (INS) group, diabetic rats treated with gliclazide per os （PO） group, and normal control (NC) group. The diabetic rats in INS group and PO group were given insulin and gliclazide for 3 weeks, respectively. The changes of the liver fatty were evaluated with oil red O staining. Fasting plasma adiponectin concentration was measured by ELISA. The expression of adiponectin receptor 1 (AdipoR1) was detected by real-time PCR. The protein levels of AMP-activated protein kinase (AMPK), phosphorylated AMPK on threonine 172 (Thr172p-AMPK), sterol regulatory element-binding protein 1c (SREBP-1c), phosphorylated SREBP-1c on serine 372 (Ser372p-SREBP-1c), acetyl-CoA carboxylase (ACC), phosphorylated ACC on serine79 (Ser79p-ACC) and immunoglobulin-binding protein (BiP) in the liver homogenate were determined by Western blotting. RESULTS：Compared with the normal rats, in DM group, the presence of cytoplasmic lipid deposits was confirmed by oil red O staining. In INS group, these changes were significantly lower than those in DM group. Similar results were obtained in PO group. Insulin therapy significantly increased the plasma concentration of diponectin and liver tissue levels of AdipoR1 compared with DM group. At the same time, these 2 indicators returned to normal levels after gliclazide therapy. Thr172p-AMPK/AMPK, Ser372p-SREBP-1c/SREBP-1c and Ser79p-ACC/ACC expression ratios were significantly reduced in DM group compared with control values. The expression of BiP was increased on the contrary. After insulin therapy, Thr172p-AMPK/AMPK and Ser372p-SREBP-1c/SREBP-1c were significantly increased, and Ser79p-ACC/ACC and BiP returned to the normal levels. After gliclazide treatment, Thr172p-AMPK/AMPK and Ser372p-SREBP-1c/SREBP-1c returned to the normal levels, the expression ratio of Ser79p-ACC/ACC had no significant improvement compared with DM group, and the expression of BiP significantly declined. CONCLUSION：Both the insulin and gliclazide therapies reduce the lipid deposition in the liver of rats with type 2 diabetes by activating AMPK, but the extent and mechanism are not the same. In insulin therapy, AMPK restrains the expression of SREBP-1c directly, increases the phosphorylation of SREBP-1c, and affects SREBP-1c by inhibiting the endoplasmic reticulum stress. Gliclazide treatment, which has no effect on the lipid oxidation, reduces lipid deposition in the liver only through the phosphorylation of SREBP-1c and the suppression of the endoplasmic reticulum stress.     

Effects of extract of gingko biloba on the lipid metabolism and the function of macrophages from diabetic rats

AIM: To study effect of extract of ginkgo biloba (EGb) on the lipid metabolism and the function of macrophages from diabetic rats.METHODS: Sprague-Dauley rats were divided into four groups: normal control group, high-fat group, diabetic group and EGb treatment group.At the end of experiment, the rats were sacrificed, the blood glucose, blood insulin and serum lipid were measured.The activity of superoxide dismutase (SOD), content of malondialdehyde (MDA), nitric oxide (NO) in alveolar macrophages (AM) and peritoneal macrophages (PM) were assayed.In addition, peroxisome proliferator activated receptor γ (PPARγ), CD36 mRNA expression in AM was measured by RT-PCR.RESULTS: The concentration of the blood glucose, blood insulin and total cholesterol (TC), total triglycerides (TG), low-density lipoprotein- cholesterol (LDL-C) in blood increased significantly in type 2 diabetic group.The supplement of EGb decreased blood glucose, blood insulin and TC, TG, LDL-C levels.The activity of SOD decreased, while the content of NO, MDA increased in the diabetic macrophages, the activity of SOD became increased, but the content of NO and MDA decreased in EGb-treated group.The mRNA expression level of CD36 and PPARγ in alveolar macrophages from diabetic group increased, while expression level of CD36 and PPARγ mRNA in EGb treated rats continued to rise.CONCLUSIONS: EGb corrected insulin resistance and ameliorated disturbance of lipid metabolism caused by type2 diabetes in rats.Adjustment of PPARγ and CD36 mRNA expression of as well as reduction of lipid peroxidation and NO level may be involved in this process.     

Protective effects of sequoyitol on type 2 diabetic rats with liver inflammatory lesions

AIM：To investigate the possible protective effect of sequoyitol on type 2 diabetic rats with liver inflammatory lesions. METHODS：Type 2 diabetic rats were induced by feeding high-fat/high-sugar diet and injecting with a low dose of streptozotocin. Sequoyitol at doses of 12.5, 25 and 50 mg·kg-1·d-1 was orally administered in the model rats. At the end of the experiment, the rats were sacrificed. Serum levels of fasting blood glucose, alanine aminotransferase(ALT), aspartate aminotransferase(AST) and albumin(ALB) were determined. Liver wet was recorded and liver index was calculated. The levels of C-reactive protein(CRP),tumor necrosis factor α(TNF-α) and interleukin 6(IL-6) in the liver tissues were also measured. Real-time PCR was used to determine the mRNA expression of TNF-α. In addition, the pathological changes of the liver were observed with HE staining. RESULTS：Compared with the model rats, treatment with sequoyitol obviously decreased the levels of fasting blood glucose, ALT, AST, ALB, CRP, TNF-α and IL-6, reduced the liver index, down-regulated the mRNA expression of TNF-α in the liver, and ameliorated the pathologic changes of the liver. CONCLUSION：Sequoyitol attenuates liver lesions in type 2 diabetic rats through down-regulation of TNF-α and IL-6 expression.     

Oxygen free radical injury of myocardial mitochondria in the experimental type 2 diabetic rats

AIM: To study the mechanism of diabetic cardiomyopathy and abnormality of oxygen free radicals. METHODS: The contents of myocardial cytosolic cytochrome C, mitochondria cytochrome C, mitochondrial calcium, NO, MDA and the activity of SOD and NOS were determined in diabetic rats induced by STZ. The pathological changes were observed under transmission electron microscope. RESULTS: Compared to the normal and ganoderma group, the levels of mitochondrial NO, iNOS, MDA, calcium and plasma Cyt-C in rat myocardium were higher (P<0.05), while mitochondrial Cyt-C and SOD were lowered in model group (P<0.05). The bouncary indistinct, disorganization, a focal loss of muscular fibril, myocardium mitochondria swelling, pulmonary vascular endothelial cellular swelling and obstructed lumen of the capillary were also observed under transmission electronic microscope. CONCLUSION: The findings indicate that oxyradical and lipid peroxidation might be associated with the damage of myocardial mitochondria in NIDDM rats. Cyt-C and mitochondrial calcium is also involved in the process.     

Effect of Ginkgo biloba extract on the expression of connective tissue growth factor in the initiating stage of fibrosis in lungs of rats

AIM: To study the effect of Ginkgo biloba extract (GbE) on the expression of connective tissue growth factor (CTGF) in the initiating stage of pulmonary fibrosis of rats after administration of bleomycin (BLM).METHODS: The expression of CTGF in lungs was detected by Western blotting. The content of hydroxyproline was assayed by the method of chloramines T. The content of malondialdehyde (MDA) in plasma was investigated by colorimetry.RESULTS: On day 14 after administration of BLM, the contents of CTGF in lungs and MDA in plasma in BLM+NS group were higher than those in NS group, respectively (P<0.05; P<0.01). On day 30 after BLM, the contents of hydroxyproline in lungs and MDA in plasma in BLM+NS group were higher than those in NS group, respectively (both P<0.01). Treatment with GbE ameliorated the above changes induced by BLM. CONCLUSION: GbE ameliorates the up-regulation of CTGF in the initial stage of fibrosis in lungs of rats after administration of BLM. GbE prevents the hyperoxidative injury in lungs of rats after BLM, which might be one of mechanisms underling the effect of GbE on CTGF.     

Immunohistochemical observation and imaging analysis of iNOS and vasoactive intestinal peptide in experimental diabetic rat lung

AIM: The pathological changes in inducible nitric oxide synthase (iNOS) and vasoactive intestinal peptide (VIP) in diabetic rat lung were investigated.METHODS: Using immunohistochemical method and imaging analysis, the changes in iNOS and VIP were observed in normal and diabetic rat lung. RESULTS: In diabetic rats, the iNOS positive or weak positive staining was localized in epithelial cells of bronchi, epithelial cells of alveolar ducts, alveolar sacs, and arteries, but negative in endothelial cells of vein and capillary. Image analysis showed the area, the integral absorbance(IA) and relative contents of iNOS were significant lower than that of control (P＜0.01, P＜0.01 and P＜0.01). In diabetic rats, the ciliated cells of bronchi epithelium showed VIP positive reaction, while the bronchial smooth muscle, surounding tracheobronchial submucosal glands, the tunica adventitia of pulmonary arteries, and alveolar septum were stained weak positive or negative for VIP. Image analysis showed the area, the IA and relative contents of VIP were significantly lower than those of control (P＜0.01, P＜0.01 and P＜0.01).CONCLUSION: The pathological changes in diabetic rat lungs are not only involving autonomic neuropathy but also NANC nerves. Nitric oxide and VIP, which are NANC neurotransmitter, may play an important role in pathogenesis of pathological change in diabetic lung.     

Effect of curcumin derivative B06 Bob on synthesis of testosterone from type 2 diabetic rats

AIM: To investigate the effect of curcumin derivatives B06(B06) on the synthesis of testosterone from type 2 diabetic rats. METHODS: Male Sprague-Dawley rats were evenly divided into 5 groups randomly: normal control group (C group), high fat group (H group), high fat treatment group (HT group), diabetes mellitus group (D group) and diabetes treatment group (DT group). The rats in the later 4 groups were fed with high fat diet, after 4 weeks of high fat diet feeding, the rats from D group and DT group were injected with low dose of streptozotocin intraperitoneally to induce diabetes mellitus, while the rats in HT group and DT group were gavaged with B06 at the dose of 0.2 mg·kg^-1·d^-1 for 8 weeks. The blood glucose was detected by glucometer, blood insulin was assayed by ELISA and the insulin resistance index was calculated. The morphology of testes were observed by light and transmission electron microscopy. Serum testosterone and estradiol were measured by radioimmunoassay. The protein expression of steroidogenic acute regulatory protein (StAR) was detected by immunohistochemistry. The mRNA expression of StAR, cholesterol side-chain cleavage enzyme (P450scc), cytochrome P450 17A1 (P450c17), cytochrome P450 aromatizing enzyme (P450arom), 3β-hydroxysteroid dehydrogenase (HSD) and 17β-HSD was detected by RT-PCR. RESULTS: The levels of blood glucose and insulin resistance index were increased in H group and D group, and serum testosterone was decreased, all of which were reversed after the treatment of B06. Testicular seminiferous tubule was distorted, spermatogenic cells were dropped in H group and D group. In addition, leydig cells were found to have swelling mitochondria in H group and D group, endoplasmic reticulum was reduced, and there was karyopyknosis accompany with sparse chromatin, all of which were ameliorated by B06. The protein expression of StAR was decreased in D group. The mRNA expression of StAR and P450scc was decreased in H group and D group, all of which were increased in B06 treatment group. There was no significant difference in the mRNA expression of P450c17, P450arom, 3β-HSD and 17β-HSD. CONCLUSION: B06 may increase serum testosterone and relieve the damage of testes from type 2 diabetic rats. B06 improves metabolic disorder by up-regulating mRNA expression of StAR and P450scc.     

Effect of caveolin-1 expression on high-salt diet-induced endothelial dysfunction in type 1 diabetic rats

AIM: To investigate the underlying mechanisms responsible for endothelial dysfunction of type 1 diabetes mellitus (DM) rats fed with high-salt diet. METHODS: Type 1 DM was induced by intraperitoneal injection of streptozotocin (70 mg/kg). Normal and diabetic rats were fed high-salt food (HS, 8% NaCl) and standard food for 6 weeks, respectively. Isometric tension of the mesenteric arteries were measured. The expression of Akt, endothelial nitric oxide synthase (eNOS) and caveolin-1 (Cav-1) was examined by Western blot. RESULTS: The rats in DM+HS group exhibited more pronounced impairment of vasorelaxation to acetylcholine and insulin compared with either DM group or HS group (P<0.01). Akt and eNOS phosphorylation levels, and nitric oxide (NO) concentration in DM+HS group were significantly lower than those in DM group (P<0.01). The level of Cav-1 in DM+HS group was significantly higher than that in DM group and HS group. CONCLUSION: Impaired endothelial Akt activation, increased Cav-1 expression and resultant decreased eNOS activation contribute to aggravate high-salt diet-induced endothelial dysfunction and hypertension in DM rats.     

The protective effects of angiotensin Ⅱ receptor blocker irbesartan on kidney function in diabetic rats

AIM: To investigate the effects and mechanisms of irbesartan, one of the angiotensin Ⅱreceptor blockers, on kidney function in diabetic rats. METHODS: Forty adult male Wistar rats were randomly divided into four groups: control group, diabetes group, irbesartan group and captopril group. At the end of 12 weeks, the rats were sacrificed. Urine volume, body weight, kidney weight/body weight, plasma, glucose, glycosylated hemoglobin (HbA₁c), urinary β₂-microglobulin (β₂-MG) excretion, urinary albumin excretion rate (UAR), creatinine clearance (Ccr) were measured. Nitric oxide (NO) and endothelin-1 (ET-1) levels in plasma, urinary and renal tissues were determined. RESULTS: Urine volume, kidney weight/body weight, plasma glucose, HbA1C, UAR, Ccr, urinary β₂-MG excretion, NO and ET-1 levels of urinary, blood and renal tissue in diabetic rats were significantly higher than those of normal controls ( P<0.01). UAR, Ccr, urinary β₂-MG excretion, ET-1 and NO levels of urinary and renal tissue in rats of irbesartan and captopril groups were significantly lower than those of DM rats ( P<0.01). There were positive relationships among the levels of plasma, urinary, renal tissue ET-1, NO and UAR, Ccr and urinary β₂-MG excretion. CONCLUSION: Irbesartan could prevent from the injury of renal function in STZ-induced diabetic rats. And it maybe one of the most importan mechanisms that irbesartan could reduce the NO and ET-1 levels in STZ-induced diabetic rats.     

Effect of aerobic exercise on myenteric plexus and colonic dysfunction in type 2 diabetic rats

AIM: To observe the effect of aerobic exercise and dietary patterns on the colonic function of type 2 diabetic rats and the enteric nervous mechanism.METHODS: The rat model of type 2 diabetes was induced by high-fat diet (HFD) and streptozotocin (30 mg/kg, ip) injection, and the rats were divided into diabetes control (DC) group, HFD group, exercise (E) group and exercise combined with high fat diet (E+HFD) group. Some other healthy rats were arranged into normal control (NC) group. The rats in E group and E+HFD group received 8-week swimming training (5 d/week, 60 min/d). The colon samples were collected at the end of the 8th week for observation of the pathological changes by HE staining and for detection of colonic tension and expression of protein gene product 9.5(PGP9.5), substance P(SP) and vasoactive intestinal peptide (VIP).RESULTS: Diabetes induced significant myenteric plexus damages and marked reduction of neurons, while exercise protected the enteric nervous system from injuries. The expression of SP significantly increased in the rats with long-term aerobic exercise combined with a reasonable diet. However, high-fat diet combined with exercise did not obviously up-regulate SP. The positive expression of VIP in the colon significantly increased in both E group and E+HFD group. Aerobic exercise attenuated the atrophy and increased the tension in colonic smooth muscles.CONCLUSION: Diabetes induces muscular atrophy and tension attenuation in colonic smooth muscle, which can be reversed in some extent by aerobic exercise through the remolding of enteric nervous system.